Innovation and Commercialization Specialists

Aimee Arnoldussen, PhD

Cognitive neuroscientist with expertise in medical and assistive technologies. Start-up, healthcare, research funding and FDA.

Abram Becker

Expertise in commercial strategy for pharmaceuticals, biotech, medical devices, and diagnostics. Start-up, non-profit, & Fortune 500 experience.

Cecily Brose

Expertise in consumer product development and commercialization. Led innovation platforms in the food industry.

David Ertl

Product management and strategy expertise in information technology. Silicon Valley, start-up, and Fortune 500 experience.

Kieran Furlong

Expertise in early-stage company building, venture capital, cleantech, agtech and manufacturing. VC investor & start-up veteran.

Upcoming Programs and Events from the Innovate Network

News from the Innovate Network

UW Spinout FoodChain Acquired by the Dohmen Company

FOR IMMEDIATE RELEASE                           April 3, 2020  The Dohmen Company announced on Thursday that they have acquired FoodChain, a UW–Madison spinout focused on connecting farmers, suppliers, and consumers with an innovative online marketplace. FoodChain’s platform allows …

FluGen, UW-Madison researchers developing COVID-19 vaccine

UW-Madison researchers and the vaccine companies FluGen and Bharat Biotech are developing and testing a vaccine against COVID-19 called CoroFlu, they announced Thursday. CoroFlu will build on FluGen’s flu vaccine candidate known as M2SR. That …

UW–Madison, FluGen, Bharat Biotech to develop CoroFlu, a coronavirus vaccine

Refinement of the CoroFlu vaccine concept and testing in laboratory animal models at UW–Madison is expected to take three to six months. CoroFlu could be in human clinical trials by fall, 2020.